Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexander Rotenberg, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Alexander Rotenberg and Steven Schachter.
Connection Strength

0.821
  1. Alterations in the Timing of Huperzine A Cerebral Pharmacodynamics in the Acute Traumatic Brain Injury Setting. J Neurotrauma. 2018 01 15; 35(2):393-397.
    View in: PubMed
    Score: 0.184
  2. Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease. Med Hypotheses. 2017 Feb; 99:57-62.
    View in: PubMed
    Score: 0.173
  3. Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research. Expert Rev Neurother. 2016 06; 16(6):671-80.
    View in: PubMed
    Score: 0.165
  4. Huperzine A prophylaxis against pentylenetetrazole-induced seizures in rats is associated with increased cortical inhibition. Epilepsy Res. 2015 Nov; 117:97-103.
    View in: PubMed
    Score: 0.158
  5. Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav. 2009 Jan; 14(1):253-7.
    View in: PubMed
    Score: 0.098
  6. Surface EEG-Transcranial Direct Current Stimulation (tDCS) Closed-Loop System. Int J Neural Syst. 2017 Sep; 27(6):1750026.
    View in: PubMed
    Score: 0.044
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.